Molecular mechanisms of cell death: Central implication of ATP synthase in mitochondrial permeability transition

Oncogene

Volumn 34, Issue 12, 2015, Pages 1475-1486

  Bonora, M ^a   Wieckowski, M R ^b   Chinopoulos, C ^c   Kepp, O ^d,e,f   Kroemer, G ^d,e,f,g   Galluzzi, L ^d,e,f   Pinton, P ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d CENTRE DE RECHERCHE DES CORDELIERS   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f INSTITUT GUSTAVE ROUSSY   (France)

^g HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CYCLOPHILIN; CYCLOPHILIN D; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

ANIMAL; CELL DEATH; CELL MEMBRANE PERMEABILITY; CHEMISTRY; HUMAN; METABOLISM; MITOCHONDRIAL MEMBRANE; MITOCHONDRION;

ANIMALS; CELL DEATH; CELL MEMBRANE PERMEABILITY; CHEMISTRY; CYCLOPHILINS; HUMANS; METABOLISM; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MITOCHONDRIAL MEMBRANES; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES;

EID: 84897967621     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.96     Document Type: Review

References (219)

1. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007; 87: 99-163.
2. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012, 19: 107-120.
3. Brenner C, Grimm S. The permeability transition pore complex in cancer cell death. Oncogene 2006; 25: 4744-4756.
4. Hunter DR, Haworth RA. The Ca2+-induced membrane transition in mitochondria. I. The protective mechanisms. Arch Biochem Biophys 1979; 195: 453-459.
5. Zamzami N, Marchetti P, Castedo M, Decaudin D, Macho A, Hirsch T et al. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 1995; 182: 367-377.
6. Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssiere JL, Petit PX et al. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med 1995; 181: 1661-1672.
7. Green DR, Galluzzi L, Kroemer G. Mitochondria and the autophagy-inflammationcell death axis in organismal aging. Science 2011; 333: 1109-1112.
8. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 2010; 11: 700-714.
9. Bonora M, Patergnani S, Rimessi A, De Marchi E, Suski JM, Bononi A et al. ATP synthesis and storage. Purinergic Signal 2012; 8: 343-357.
10. Galluzzi L, Kepp O, Kroemer G. Mitochondria: master regulators of danger signalling. Nat Rev Mol Cell Biol 2012; 13: 780-788.
11. Tait SW, Green DR. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 2010; 11: 621-632.
12. Munoz-Pinedo C, Guio-Carrion A, Goldstein JC, Fitzgerald P, Newmeyer DD, Green DR. Different mitochondrial intermembrane space proteins are released during apoptosis in a manner that is coordinately initiated but can vary in duration. Proc Natl Acad Sci USA 2006; 103: 11573-11578.
13. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 2009, 16: 3-11.
14. Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 2008; 9: 231-241.
15. Leist M, Single B, Castoldi AF, Kuhnle S, Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 1997; 185: 1481-1486.
16. Mannick JB, Schonhoff C, Papeta N, Ghafourifar P, Szibor M, Fang K et al. S-nitrosylation of mitochondrial caspases. J Cell Biol 2001; 154: 1111-1116.
17. Jost PJ, Grabow S, Gray D, McKenzie MD, Nachbur U, Huang DC et al. XIAP discriminates between type I and type II FAS-induced apoptosis. Nature 2009; 460: 1035-1039.
18. Oberst A, Dillon CP, Weinlich R, McCormick LL, Fitzgerald P, Pop C et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 2011; 471: 363-367.
19. Hirsch T, Marchetti P, Susin SA, Dallaporta B, Zamzami N, Marzo I et al. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 1997; 15: 1573-1581.
20. Schinzel AC, Takeuchi O, Huang Z, Fisher JK, Zhou Z, Rubens J et al. Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc Natl Acad Sci USA 2005; 102: 12005-12010.
21. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 2005; 434: 658-662.
22. Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005; 434: 652-658.
23. Whelan RS, Konstantinidis K, Wei AC, Chen Y, Reyna DE, Jha S et al. Bax regulates primary necrosis through mitochondrial dynamics. Proc Natl Acad Sci USA 2012; 109: 6566-6571.
24. Linkermann A, Brasen JH, Darding M, Jin MK, Sanz AB, Heller JO et al. Two independent pathways of regulated necrosis mediate ischemiareperfusion injury. Proc Natl Acad Sci USA 2013; 110: 12024-12029.
25. Thomas B, Banerjee R, Starkova NN, Zhang SF, Calingasan NY, Yang L et al. Mitochondrial permeability transition pore component cyclophilin D distinguishes nigrostriatal dopaminergic death paradigms in the MPTP mouse model of Parkinson's disease. Antioxid Redox Signal 2012; 16: 855-868.
26. Ramachandran A, Lebofsky M, Baines CP, Lemasters JJ, Jaeschke H. Cyclophilin D deficiency protects against acetaminophen-induced oxidant stress and liver injury. Free Radic Res 2011; 45: 156-164.
27. LoGuidice A, Ramirez-Alcantara V, Proli A, Gavillet B, Boelsterli UA. Pharmacologic targeting or genetic deletion of mitochondrial cyclophilin D protects from NSAID-induced small intestinal ulceration in mice. Toxicol Sci 2010; 118: 276-285.
28. Haouzi D, Cohen I, Vieira HL, Poncet D, Boya P, Castedo M et al. Mitochondrial permeability transition as a novel principle of hepatorenal toxicity in vivo. Apoptosis 2002; 7: 395-405.
29. Fujimoto K, Chen Y, Polonsky KS, Dorn GW2nd. Targeting cyclophilin D and the mitochondrial permeability transition enhances beta-cell survival and prevents diabetes in Pdx1 deficiency. Proc Natl Acad Sci USA 2010; 107: 10214-10219.
30. Palma E, Tiepolo T, Angelin A, Sabatelli P, Maraldi NM, Basso E et al. Genetic ablation of cyclophilin D rescues mitochondrial defects and prevents muscle apoptosis in collagen VI myopathic mice. Hum Mol Genet 2009; 18: 2024-2031.
31. Millay DP, Sargent MA, Osinska H, Baines CP, Barton ER, Vuagniaux G et al. Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy. Nat Med 2008; 14: 442-447.
32. Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O et al. Molecular mechanisms of cisplatin resistance. Oncogene 2012; 31: 1869-1883.
33. Chipuk JE, Fisher JC, Dillon CP, Kriwacki RW, Kuwana T, Green DR. Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins. Proc Natl Acad Sci USA 2008; 105: 20327-20332.
34. Peng R, Tong JS, Li H, Yue B, Zou F, Yu J et al. Targeting Bax interaction sites reveals that only homo-oligomerization sites are essential for its activation. Cell Death Differ 2013; 20: 744-754.
35. Galluzzi L, Blomgren K, Kroemer G. Mitochondrial membrane permeabilization in neuronal injury. Nat Rev Neurosci 2009; 10: 481-494.
36. Fulda S, Galluzzi L, Kroemer G. Targeting mitochondria for cancer therapy. Nat Rev Drug Discov 2010; 9: 447-464.
37. Galluzzi L, Larochette N, Zamzami N, Kroemer G. Mitochondria as therapeutic targets for cancer chemotherapy. Oncogene 2006; 25: 4812-4830.
38. Martel C, Huynh le H, Garnier A, Ventura-Clapier R, Brenner C. Inhibition of the mitochondrial permeability transition for cytoprotection: direct versus indirect Mechanisms. Biochem Res Int 2012; 2012: 213-403.
39. Kepp O, Galluzzi L, Lipinski M, Yuan J, Kroemer G. Cell death assays for drug discovery. Nat Rev Drug Discov 2011; 10: 221-237.
40. Kahan BD. Individuality: the barrier to optimal immunosuppression. Nat Rev Immunol 2003; 3: 831-838.
41. Borner C, Andrews DW. The apoptotic pore on mitochondria: are we breaking through or still stuck? Cell Death Differ 2014; 21: 187-191
42. Szabo I, Zoratti M. The mitochondrial megachannel is the permeability transition pore. J Bioenerg Biomembr 1992; 24: 111-117.
43. Szabo I, Bernardi P, Zoratti M. Modulation of the mitochondrial megachannel by divalent cations and protons. J Biol Chem 1992; 267: 2940-2946.
44. Szabo I, Zoratti M. The mitochondrial permeability transition pore may comprise VDAC molecules. I. Binary structure and voltage dependence of the pore. FEBS Lett 1993; 330: 201-205.
45. Szabo I, De Pinto V, Zoratti M. The mitochondrial permeability transition pore may comprise VDAC molecules. II. The electrophysiological properties of VDAC are compatible with those of the mitochondrial megachannel. FEBS Lett 1993; 330: 206-210.
46. McEnery MW, Snowman AM, Trifiletti RR, Snyder SH. Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc Natl Acad Sci USA 1992; 89: 3170-3174.
47. Beutner G, Ruck A, Riede B, Welte W, Brdiczka D. Complexes between kinases, mitochondrial porin and adenylate translocator in rat brain resemble the permeability transition pore. FEBS Lett 1996; 396: 189-195.
48. Beutner G, Ruck A, Riede B, Brdiczka D. Complexes between porin, hexokinase, mitochondrial creatine kinase and adenylate translocator display properties of the permeability transition pore. Implication for regulation of permeability transition by the kinases. Biochim Biophys Acta 1998; 1368: 7-18.
49. Crompton M, Virji S, Ward JM. Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore. Eur J Biochem 1998; 258: 729-735.
50. Tanveer A, Virji S, Andreeva L, Totty NF, Hsuan JJ, Ward JM et al. Involvement of cyclophilin D in the activation of a mitochondrial pore by Ca2+ and oxidant stress. Eur J Biochem 1996; 238: 166-172.
51. Halestrap AP, Davidson AM. Inhibition of Ca2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem J 1990; 268: 153-160.
52. Ruck A, Dolder M, Wallimann T, Brdiczka D. Reconstituted adenine nucleotide translocase forms a channel for small molecules comparable to the mitochondrial permeability transition pore. FEBS Lett 1998; 426: 97-101.
53. Kokoszka JE, Waymire KG, Levy SE, Sligh JE, Cai J, Jones DP et al. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 2004; 427: 461-465.
54. Baines CP, Kaiser RA, Sheiko T, Craigen WJ, Molkentin JD. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol 2007; 9: 550-555.
55. Galluzzi L, Kroemer G. Mitochondrial apoptosis without VDAC. Nat Cell Biol 2007; 9: 487-489.
56. Basso E, Fante L, Fowlkes J, Petronilli V, Forte MA, Bernardi P. Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D. J Biol Chem 2005; 280: 18558-18561.
57. Dolce V, Scarcia P, Iacopetta D, Palmieri F. A fourth ADP/ATP carrier isoform in man: identification, bacterial expression, functional characterization and tissue distribution. FEBS Lett 2005; 579: 633-637.
58. Zamora M, Granell M, Mampel T, Vinas O. Adenine nucleotide translocase 3 (ANT3) overexpression induces apoptosis in cultured cells. FEBS Lett 2004; 563: 155-160.
59. Cheng EH, Sheiko TV, Fisher JK, Craigen WJ, Korsmeyer SJ. VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science 2003; 301: 513-517.
60. Desagher S, Osen-Sand A, Nichols A, Eskes R, Montessuit S, Lauper S et al. Bidinduced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol 1999; 144: 891-901.
61. Tedeschi H, Hegarty HJ, James JM. Osmotic reversal of phosphate-induced mitochondrial swelling. Biochim Biophys Acta 1965; 104: 612-615.
62. Palmieri F. The mitochondrial transporter family (SLC25): physiological and pathological implications. Pflugers Arch 2004; 447: 689-709.
63. Hagen T, Lagace CJ, Modica-Napolitano JS, Aprille JR. Permeability transition in rat liver mitochondria is modulated by the ATP-Mg/Pi carrier. Am J Physiol Gastrointest Liver Physiol 2003; 285: G274-G281.
64. Traba J, Del Arco A, Duchen MR, Szabadkai G, Satrustegui J. SCaMC-1 promotes cancer cell survival by desensitizing mitochondrial permeability transition via ATP/ADP-mediated matrix Ca(2+) buffering. Cell Death Differ 2012; 19: 650-660.
65. Poncet D, Pauleau AL, Szabadkai G, Vozza A, Scholz SR, Le Bras M et al. Cytopathic effects of the cytomegalovirus-encoded apoptosis inhibitory protein vMIA. J Cell Biol 2006; 174: 985-996.
66. Galluzzi L, Brenner C, Morselli E, Touat Z, Kroemer G. Viral control of mitochondrial apoptosis. PLoS Pathog 2008; 4: e1000018.
67. Leung AW, Varanyuwatana P, Halestrap AP. The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition. J Biol Chem 2008; 283: 26312-26323.
68. Alcala S, Klee M, Fernandez J, Fleischer A, Pimentel-Muinos FX. A highthroughput screening for mammalian cell death effectors identifies the mitochondrial phosphate carrier as a regulator of cytochrome c release. Oncogene 2008; 27: 44-54.
69. Schroers A, Kramer R, Wohlrab H. The reversible antiport-uniport conversion of the phosphate carrier from yeast mitochondria depends on the presence of a single cysteine. J Biol Chem 1997; 272: 10558-10564.
70. Varanyuwatana P, Halestrap AP. The roles of phosphate and the phosphate carrier in the mitochondrial permeability transition pore. Mitochondrion 2012; 12: 120-125.
71. Pauleau AL, Galluzzi L, Scholz SR, Larochette N, Kepp O, Kroemer G. Unexpected role of the phosphate carrier in mitochondrial fragmentation. Cell Death Differ 2008; 15: 616-618.
72. Verrier F, Deniaud A, Lebras M, Metivier D, Kroemer G, Mignotte B et al. Dynamic evolution of the adenine nucleotide translocase interactome during chemotherapy-induced apoptosis. Oncogene 2004; 23: 8049-8064.
73. Mukhin AG, Papadopoulos V, Costa E, Krueger KE. Mitochondrial benzodiazepine receptors regulate steroid biosynthesis. Proc Natl Acad Sci USA 1989; 86: 9813-9816.
74. Pastorino JG, Simbula G, Gilfor E, Hoek JB, Farber JL. Protoporphyrin IX, an endogenous ligand of the peripheral benzodiazepine receptor, potentiates induction of the mitochondrial permeability transition and the killing of cultured hepatocytes by rotenone. J Biol Chem 1994; 269: 31041-31046.
75. Hirsch T, Decaudin D, Susin SA, Marchetti P, Larochette N, Resche-Rigon M et al. PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection. Exp Cell Res 1998; 241: 426-434.
76. Chelli B, Falleni A, Salvetti F, Gremigni V, Lucacchini A, Martini C. Peripheral-type benzodiazepine receptor ligands: mitochondrial permeability transition induction in rat cardiac tissue. Biochem Pharmacol 2001; 61: 695-705.
77. Azarashvili T, Grachev D, Krestinina O, Evtodienko Y, Yurkov I, Papadopoulos V et al. The peripheral-type benzodiazepine receptor is involved in control of Ca2 +-induced permeability transition pore opening in rat brain mitochondria. Cell Calcium 2007; 42: 27-39.
78. Klaffschenkel RA, Waidmann M, Northoff H, Mahmoud AA, Lembert N. PK11195, a specific ligand of the peripheral benzodiazepine receptor, may protect pancreatic beta-cells from cytokine-induced cell death. Artif Cells Blood Substit Immobil Biotechnol 2012; 40: 56-61.
79. Kugler W, Veenman L, Shandalov Y, Leschiner S, Spanier I, Lakomek M et al. Ligands of the mitochondrial 18 kDa translocator protein attenuate apoptosis of human glioblastoma cells exposed to erucylphosphohomocholine. Cell Oncol 2008; 30: 435-450.
80. Shargorodsky L, Veenman L, Caballero B, Pe'er Y, Leschiner S, Bode J et al. The nitric oxide donor sodium nitroprusside requires the 18 kDa Translocator Protein to induce cell death. Apoptosis 2012; 17: 647-665.
81. Campanella M, Szabadkai G, Rizzuto R. Modulation of intracellular Ca2+ signalling in HeLa cells by the apoptotic cell death enhancer PK11195. Biochem Pharmacol 2008; 76: 1628-1636.
82. Decaudin D, Castedo M, Nemati F, Beurdeley-Thomas A, De Pinieux G, Caron A et al. Peripheral benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo. Cancer Res 2002; 62: 1388-1393.
83. Gonzalez-Polo RA, Carvalho G, Braun T, Decaudin D, Fabre C, Larochette N et al. PK11195 potently sensitizes to apoptosis induction independently from the peripheral benzodiazepin receptor. Oncogene 2005; 24: 7503-7513.
84. Wallimann T, Dolder M, Schlattner U, Eder M, Hornemann T, O'Gorman E et al. Some new aspects of creatine kinase (CK): compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology. Biofactors 1998; 8: 229-234.
85. Dolder M, Walzel B, Speer O, Schlattner U, Wallimann T. Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation. J Biol Chem 2003; 278: 17760-17766.
86. Wilson JE. Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J Exp Biol 2003; 206: 2049-2057.
87. Pastorino JG, Hoek JB. Regulation of hexokinase binding to VDAC. J Bioenerg Biomembr 2008; 40: 171-182.
88. Pastorino JG, Hoek JB. Hexokinase II: the integration of energy metabolism and control of apoptosis. Curr Med Chem 2003; 10: 1535-1551.
89. Galluzzi L, Kepp O, Tajeddine N, Kroemer G. Disruption of the hexokinase-VDAC complex for tumor therapy. Oncogene 2008; 27: 4633-4635.
90. Goldin N, Arzoine L, Heyfets A, Israelson A, Zaslavsky Z, Bravman T et al. Methyl jasmonate binds to and detaches mitochondria-bound hexokinase. Oncogene 2008; 27: 4636-4643.
91. Arzoine L, Zilberberg N, Ben-Romano R, Shoshan-Barmatz V. Voltage-dependent anion channel 1-based peptides interact with hexokinase to prevent its antiapoptotic activity. J Biol Chem 2009; 284: 3946-3955.
92. Smeele KM, Southworth R, Wu R, Xie C, Nederlof R, Warley A et al. Disruption of hexokinase II-mitochondrial binding blocks ischemic preconditioning and causes rapid cardiac necrosis. Circ Res 2011; 108: 1165-1169.
93. Galluzzi L, Kepp O, Vander Heiden MG, Kroemer G. Metabolic targets for cancer therapy. Nat Rev Drug Discov 2013; 12: 829-846.
94. Sun L, Shukair S, Naik TJ, Moazed F, Ardehali H. Glucose phosphorylation and mitochondrial binding are required for the protective effects of hexokinases I and II. Mol Cell Biol 2008; 28: 1007-1017.
95. Chiara F, Castellaro D, Marin O, Petronilli V, Brusilow WS, Juhaszova M et al. Hexokinase II detachment from mitochondria triggers apoptosis through the permeability transition pore independent of voltage-dependent anion channels. PLoS ONE 2008; 3: e1852.
96. Schindler A, Foley E. Hexokinase 1 blocks apoptotic signals at the mitochondria. Cell Signal 2013; 25: 2685-2692.
97. Pastorino JG, Hoek JB, Shulga N. Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity. Cancer Res 2005; 65: 10545-10554.
98. Baines CP, Song CX, Zheng YT, Wang GW, Zhang J, Wang OL et al. Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res 2003; 92: 873-880.
99. Takuma K, Phuagphong P, Lee E, Mori K, Baba A, Matsuda T. Anti-apoptotic effect of cGMP in cultured astrocytes: inhibition by cGMP-dependent protein kinase of mitochondrial permeable transition pore. J Biol Chem 2001; 276: 48093-48099.
100. Das S, Wong R, Rajapakse N, Murphy E, Steenbergen C. Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation. Circ Res 2008; 103: 983-991.
101. Nishihara M, Miura T, Miki T, Tanno M, Yano T, Naitoh K et al. Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection. J Mol Cell Cardiol 2007; 43: 564-570.
102. Chiara F, Gambalunga A, Sciacovelli M, Nicolli A, Ronconi L, Fregona D et al. Chemotherapeutic induction of mitochondrial oxidative stress activates GSK-3alpha/beta and Bax, leading to permeability transition pore opening and tumor cell death. Cell Death Dis 2012; 3: e444.
103. Rasola A, Sciacovelli M, Chiara F, Pantic B, Brusilow WS, Bernardi P. Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition. Proc Natl Acad Sci USA 2010; 107: 726-731.
104. Korzick DH, Kostyak JC, Hunter JC, Saupe KW. Local delivery of PKCepsilonactivating peptide mimics ischemic preconditioning in aged hearts through GSK-3beta but not F1-ATPase inactivation. Am J Physiol Heart Circ Physiol 2007; 293: H2056-H2063.
105. Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW et al. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 2004; 113: 1535-1549.
106. Pediaditakis P, Kim JS, He L, Zhang X, Graves LM, Lemasters JJ. Inhibition of the mitochondrial permeability transition by protein kinase A in rat liver mitochondria and hepatocytes. Biochem J 2010; 431: 411-421.
107. Juhaszova M, Zorov DB, Yaniv Y, Nuss HB, Wang S, Sollott SJ. Role of glycogen synthase kinase-3beta in cardioprotection. Circ Res 2009; 104: 1240-1252.
108. Marzo I, Brenner C, Zamzami N, Jurgensmeier JM, Susin SA, Vieira HL et al. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 1998; 281: 2027-2031.
109. Brenner C, Cadiou H, Vieira HL, Zamzami N, Marzo I, Xie Z et al. Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator. Oncogene 2000; 19: 329-336.
110. Zamzami N, El Hamel C, Maisse C, Brenner C, Munoz-Pinedo C, Belzacq AS et al. Bid acts on the permeability transition pore complex to induce apoptosis. Oncogene 2000; 19: 6342-6350.
111. Shimizu S, Narita M, Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 1999; 399: 483-487.
112. Vander Heiden MG, Chandel NS, Schumacker PT, Thompson CB. Bcl-xL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange. Mol Cell 1999; 3: 159-167.
113. Roy SS, Madesh M, Davies E, Antonsson B, Danial N, Hajnoczky G. Bad targets the permeability transition pore independent of Bax or Bak to switch between Ca2+-dependent cell survival and death. Mol Cell 2009; 33: 377-388.
114. Arbel N, Ben-Hail D, Shoshan-Barmatz V. Mediation of the antiapoptotic activity of Bcl-xL protein upon interaction with VDAC1 protein. J Biol Chem 2012; 287: 23152-23161.
115. Malia TJ, Wagner G. NMR structural investigation of the mitochondrial outer membrane protein VDAC and its interaction with antiapoptotic Bcl-xL. Biochemistry 2007; 46: 514-525.
116. Todt F, Cakir Z, Reichenbach F, Youle RJ, Edlich F. The C-terminal helix of Bcl-x(L) mediates Bax retrotranslocation from the mitochondria. Cell Death Differ 2013; 20: 333-342.
117. Vaseva AV, Marchenko ND, Ji K, Tsirka SE, Holzmann S, Moll UM. p53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell 2012; 149: 1536-1548.
118. Rufini A, Tucci P, Celardo I, Melino G. Senescence and aging: the critical roles of p53. Oncogene 2013; 32: 5129-5143.
119. Narita M, Shimizu S, Ito T, Chittenden T, Lutz RJ, Matsuda H et al. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc Natl Acad Sci USA 1998; 95: 14681-14686.
120. Karch J, Kwong JQ, Burr AR, Sargent MA, Elrod JW, Peixoto PM et al. Bax and Bak function as the outer membrane component of the mitochondrial permeability pore in regulating necrotic cell death in mice. Elife 2013; 2: e00772.
121. Scorrano L, Oakes SA, Opferman JT, Cheng EH, Sorcinelli MD, Pozzan T et al. BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis. Science 2003; 300: 135-139.
122. Marchi S, Patergnani S, Pinton P. The endoplasmic reticulum-mitochondria connection: one touch, multiple functions. Biochim Biophys Acta 2014; 1837: 461-469.
123. Marchi S, Pinton P. The mitochondrial calcium uniporter complex: molecular components, structure and physiopathological implications. J Physiol 2014; 592: 829-839 in press.
124. Patergnani S, Suski JM, Agnoletto C, Bononi A, Bonora M, De Marchi E et al. Calcium signaling around mitochondria associated membranes (MAMs). Cell Commun Signal 2011; 9: 19.
125. Giorgi C, Baldassari F, Bononi A, Bonora M, De Marchi E, Marchi S et al. Mitochondrial Ca(2+) and apoptosis. Cell Calcium 2012; 52: 36-43.
126. Giorgi C, Ito K, Lin HK, Santangelo C, Wieckowski MR, Lebiedzinska M et al. PML regulates apoptosis at endoplasmic reticulum by modulating calcium release. Science 2010; 330: 1247-1251.
127. Yoshida M, Muneyuki E, Hisabori T. ATP synthase-a marvellous rotary engine of the cell. Nat Rev Mol Cell Biol 2001; 2: 669-677.
128. Devenish RJ, Prescott M, Rodgers AJ. The structure and function of mitochondrial F1F0-ATP synthases. Int Rev Cell Mol Biol 2008; 267: 1-58.
129. Okuno D, Iino R, Noji H. Rotation and structure of FoF1-ATP synthase. J Biochem 2011; 149: 655-664.
130. Rubinstein JL, Walker JE, Henderson R. Structure of the mitochondrial ATP synthase by electron cryomicroscopy. EMBO J 2003; 22: 6182-6192.
131. Jonckheere AI, Smeitink JA, Rodenburg RJ. Mitochondrial ATP synthase: architecture, function and pathology. J Inherit Metab Dis 2012; 35: 211-225.
132. Swanljung P, Frigeri L, Ohlson K, Ernster L. Studies on the activation of purified mitochondrial ATPase by phospholipids. Biochim Biophys Acta 1973; 305: 519-533.
133. Lightowlers RN, Howitt SM, Hatch L, Gibson F, Cox G. The proton pore in the Escherichia coli F0F1-ATPase: substitution of glutamate by glutamine at position 219 of the alpha-subunit prevents F0-mediated proton permeability. Biochim Biophys Acta 1988; 933: 241-248.
134. Stephens AN, Nagley P, Devenish RJ. Each yeast mitochondrial F1F0-ATP synthase complex contains a single copy of subunit 8. Biochim Biophys Acta 2003; 1607: 181-189.
135. Mitchell P. Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism. Nature 1961; 191: 144-148.
136. Noji H, Yasuda R, Yoshida M, Kinosita K Jr. Direct observation of the rotation of F1-ATPase. Nature 1997; 386: 299-302.
137. von Ballmoos C, Wiedenmann A, Dimroth P. Essentials for ATP synthesis by F1F0 ATP synthases. Annu Rev Biochem 2009; 78: 649-672.
138. Yasuda R, Noji H, Kinosita KJr., Yoshida M. F1-ATPase is a highly efficient molecular motor that rotates with discrete 120 degree steps. Cell 1998; 93: 1117-1124.
139. Shimabukuro K, Muneyuki E, Yoshida M. An alternative reaction pathway of F1-ATPase suggested by rotation without 80 degrees/40 degrees substeps of a sluggish mutant at low ATP. Biophys J 2006; 90: 1028-1032.
140. Ariga T, Masaike T, Noji H, Yoshida M. Stepping rotation of F(1)-ATPase with one, two, or three altered catalytic sites that bind ATP only slowly. J Biol Chem 2002; 277: 24870-24874.
141. Minagawa Y, Ueno H, Hara M, Ishizuka-Katsura Y, Ohsawa N, Terada T et al. Basic properties of rotary dynamics of the molecular motor Enterococcus hirae V1-ATPase. J Biol Chem 2013; 288: 32700-32707.
142. Arai S, Saijo S, Suzuki K, Mizutani K, Kakinuma Y, Ishizuka-Katsura Y et al. Rotation mechanism of Enterococcus hirae V1-ATPase based on asymmetric crystal structures. Nature 2013; 493: 703-707.
143. Forgac M. Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat Rev Mol Cell Biol 2007; 8: 917-929.
144. Walker JE, Dickson VK. The peripheral stalk of the mitochondrial ATP synthase. Biochim Biophys Acta 2006; 1757: 286-296.
145. Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J et al. Sequence and organization of the human mitochondrial genome. Nature 1981; 290: 457-465.
146. Wittig I, Meyer B, Heide H, Steger M, Bleier L, Wumaier Z et al. Assembly and oligomerization of human ATP synthase lacking mitochondrial subunits a and A6L. Biochim Biophys Acta 2010; 1797: 1004-1011.
147. Rubinstein J, Walker J. ATP synthase from Saccharomyces cerevisiae: location of the OSCP subunit in the peripheral stalk region. J Mol Biol 2002; 321: 613-619.
148. Mayr JA, Havlickova V, Zimmermann F, Magler I, Kaplanova V, Jesina P et al. Mitochondrial ATP synthase deficiency due to a mutation in the ATP5E gene for the F1 epsilon subunit. Hum Mol Genet 2010; 19: 3430-3439.
149. Arnold I, Pfeiffer K, Neupert W, Stuart RA, Schagger H. Yeast mitochondrial F1F0-ATP synthase exists as a dimer: identification of three dimer-specific subunits. EMBO J 1998; 17: 7170-7178.
150. Habersetzer J, Ziani W, Larrieu I, Stines-Chaumeil C, Giraud MF, Brethes D et al. ATP synthase oligomerization: from the enzyme models to the mitochondrial morphology. Int J Biochem Cell Biol 2013; 45: 99-105.
151. Wittig I, Velours J, Stuart R, Schagger H. Characterization of domain interfaces in monomeric and dimeric ATP synthase. Mol Cell Proteomics 2008; 7: 995-1004.
152. Strauss M, Hofhaus G, Schroder RR, Kuhlbrandt W. Dimer ribbons of ATP synthase shape the inner mitochondrial membrane. EMBO J 2008; 27: 1154-1160.
153. Davies KM, Anselmi C, Wittig I, Faraldo-Gomez JD, Kuhlbrandt W. Structure of the yeast F1Fo-ATP synthase dimer and its role in shaping the mitochondrial cristae. Proc Natl Acad Sci USA 2012; 109: 13602-13607.
154. Dienhart M, Pfeiffer K, Schagger H, Stuart RA. Formation of the yeast F1F0-ATP synthase dimeric complex does not require the ATPase inhibitor protein, Inh1. J Biol Chem 2002; 277: 39289-39295.
155. Arselin G, Giraud MF, Dautant A, Vaillier J, Brethes D, Coulary-Salin B et al. The GxxxG motif of the transmembrane domain of subunit e is involved in the dimerization/oligomerization of the yeast ATP synthase complex in the mitochondrial membrane. Eur J Biochem 2003; 270: 1875-1884.
156. Baker LA, Watt IN, Runswick MJ, Walker JE, Rubinstein JL. Arrangement of subunits in intact mammalian mitochondrial ATP synthase determined by cryo-EM. Proc Natl Acad Sci USA 2012; 109: 11675-11680.
157. Minauro-Sanmiguel F, Wilkens S, Garcia JJ. Structure of dimeric mitochondrial ATP synthase: novel F0 bridging features and the structural basis of mitochondrial cristae biogenesis. Proc Natl Acad Sci USA 2005; 102: 12356-12358.
158. Daum B, Walter A, Horst A, Osiewacz HD, Kuhlbrandt W. Age-dependent dissociation of ATP synthase dimers and loss of inner-membrane cristae in mitochondria. Proc Natl Acad Sci USA 2013; 110: 15301-15306.
159. Campanella M, Casswell E, Chong S, Farah Z, Wieckowski MR, Abramov AY et al. Regulation of mitochondrial structure and function by the F1Fo-ATPase inhibitor protein, IF1. Cell Metab 2008; 8: 13-25.
160. Campanella M, Parker N, Tan CH, Hall AM, Duchen MR. IF(1): setting the pace of the F(1)F(o)-ATP synthase. Trends Biochem Sci 2009; 34: 343-350.
161. Garcia JJ, Morales-Rios E, Cortes-Hernandez P, Rodriguez-Zavala JS. The inhibitor protein (IF1) promotes dimerization of the mitochondrial F1F0-ATP synthase. Biochemistry 2006; 45: 12695-12703.
162. Feniouk BA, Yoshida M. Regulatory mechanisms of proton-translocating F(O)F (1)-ATP synthase. Results Probl Cell Differ 2008; 45: 279-308.
163. Gledhill JR, Montgomery MG, Leslie AG, Walker JE. How the regulatory protein, IF (1), inhibits F(1)-ATPase from bovine mitochondria. Proc Natl Acad Sci USA 2007; 104: 15671-15676.
164. Faccenda D, Campanella M. Molecular regulation of the mitochondrial F(1)F(o)-ATPsynthase: physiological and pathological significance of the inhibitory factor 1 (IF(1)). Int J Cell Biol 2012; 2012: 367934.
165. Metelkin E, Demin O, Kovacs Z, Chinopoulos C. Modeling of ATP-ADP steadystate exchange rate mediated by the adenine nucleotide translocase in isolated mitochondria. FEBS J 2009; 276: 6942-6955.
166. Chinopoulos C, Gerencser AA, Mandi M, Mathe K, Torocsik B, Doczi J et al. Forward operation of adenine nucleotide translocase during F0F1-ATPase reversal: critical role of matrix substrate-level phosphorylation. FASEB J 2010; 24: 2405-2416.
167. Chinopoulos C. Mitochondrial consumption of cytosolic ATP: not so fast. FEBS Lett 2011; 585: 1255-1259.
168. Chinopoulos C. The 'B space' of mitochondrial phosphorylation. J Neurosci Res 2011; 89: 1897-1904.
169. Kiss G, Konrad C, Doczi J, Starkov AA, Kawamata H, Manfredi G et al. The negative impact of alpha-ketoglutarate dehydrogenase complex deficiency on matrix substrate-level phosphorylation. FASEB J 2013; 27: 2392-2406.
170. Kiss G, Konrad C, Pour-Ghaz I, Mansour JJ, Nemeth B, Starkov AA et al. Mitochondrial diaphorases as NAD+ donors to segments of the citric acid cycle that support substrate-level phosphorylation yielding ATP during respiratory inhibition. FASEB J (e-pub ahead of print 3 January 2014; doi:10.1096/fj.13-243030).
171. Faccenda D, Tan CH, Seraphim A, Duchen MR, Campanella M. IF1 limits the apoptotic-signalling cascade by preventing mitochondrial remodelling. Cell Death Differ 2013; 20: 686-697.
172. Martinou JC, Youle RJ. Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell 2011; 21: 92-101.
173. Suen DF, Norris KL, Youle RJ. Mitochondrial dynamics and apoptosis. Genes Dev 2008; 22: 1577-1590.
174. Karbowski M, Norris KL, Cleland MM, Jeong SY, Youle RJ. Role of Bax and Bak in mitochondrial morphogenesis. Nature 2006; 443: 658-662.
175. Chinopoulos C, Adam-Vizi V. Modulation of the mitochondrial permeability transition by cyclophilin D: moving closer to F(0)-F(1) ATP synthase? Mitochondrion 2012; 12: 41-45.
176. Minkov IB, Fitin AF, Vasilyeva EA, Vinogradov AD. Mg2+-induced ADP-dependent inhibition of the ATPase activity of beef heart mitochondrial coupling factor F1. Biochem Biophys Res Commun 1979; 89: 1300-1306.
177. Fitin AF, Vasilyeva EA, Vinogradov AD. An inhibitory high affinity binding site for ADP in the oligomycin-sensitive ATPase of beef heart submitochondrial particles. Biochem Biophys Res Commun 1979; 86: 434-439.
178. Roveri OA, Muller JL, Wilms J, Slater EC. The pre-steady state and steady-state kinetics of the ATPase activity of mitochondrial F1. Biochim Biophys Acta 1980; 589: 241-255.
179. Drobinskaya IY, Kozlov IA, Murataliev MB, Vulfson EN. Tightly bound adenosine diphosphate, which inhibits the activity of mitochondrial F1-ATPase, is located at the catalytic site of the enzyme. FEBS Lett 1985; 182: 419-424.
180. Bulygin VV, Vinogradov AD. Interaction of Mg2+ with F0.F1 mitochondrial ATPase as related to its slow active/inactive transition. Biochem J 1991; 276(Pt 1): 149-156.
181. Galkin MA, Vinogradov AD. Energy-dependent transformation of the catalytic activities of the mitochondrial F0 x F1-ATP synthase. FEBS Lett 1999; 448: 123-126.
182. Roos I, Crompton M, Carafoli E. The role of inorganic phosphate in the release of Ca2+ from rat-liver mitochondria. Eur J Biochem 1980; 110: 319-325.
183. Crompton M, Ellinger H, Costi A. Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem J 1988; 255: 357-360.
184. Kalashnikova T, Milgrom YM, Murataliev MB. The effect of inorganic pyrophosphate on the activity and Pi-binding properties of mitochondrial F1-ATPase. Eur J Biochem 1988; 177: 213-218.
185. Moyle J, Mitchell P. Active/inactive state transitions of mitochondrial ATPase molecules influenced by Mg2+, anions and aurovertin. FEBS Lett 1975; 56: 55-61.
186. Costantini P, Belzacq AS, Vieira HL, Larochette N, de Pablo MA, Zamzami N et al. Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis. Oncogene 2000; 19: 307-314.
187. Wang SB, Murray CI, Chung HS, Van Eyk JE. Redox regulation of mitochondrial ATP synthase. Trends Cardiovasc Med 2013; 23: 14-18.
188. Bernardi P. Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore by the proton electrochemical gradient. Evidence that the pore can be opened by membrane depolarization. J Biol Chem 1992; 267: 8834-8839.
189. Petronilli V, Cola C, Bernardi P. Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore. II. The minimal requirements for pore induction underscore a key role for transmembrane electrical potential, matrix pH, and matrix Ca2+. J Biol Chem 1993; 268: 1011-1016.
190. Scorrano L, Petronilli V, Bernardi P. On the voltage dependence of the mitochondrial permeability transition pore. A critical appraisal. J Biol Chem 1997; 272: 12295-12299.
191. Wittig I, Schagger H. Structural organization of mitochondrial ATP synthase. Biochim Biophys Acta 2008; 1777: 592-598.
192. Chinopoulos C, Adam-Vizi V. Calcium, mitochondria and oxidative stress in neuronal pathology. Novel aspects of an enduring theme. FEBS J 2006; 273: 433-450.
193. Halestrap AP, Woodfield KY, Connern CP. Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. J Biol Chem 1997; 272: 3346-3354.
194. Ko YH, Delannoy M, Hullihen J, Chiu W, Pedersen PL. Mitochondrial ATP synthasome. Cristae-enriched membranes and a multiwell detergent screening assay yield dispersed single complexes containing the ATP synthase and carriers for Pi and ADP/ATP. J Biol Chem 2003; 278: 12305-12309.
195. Acin-Perez R, Fernandez-Silva P, Peleato ML, Perez-Martos A, Enriquez JA. Respiratory active mitochondrial supercomplexes. Mol Cell 2008; 32: 529-539.
196. Genova ML, Baracca A, Biondi A, Casalena G, Faccioli M, Falasca AI et al. Is supercomplex organization of the respiratory chain required for optimal electron transfer activity? Biochim Biophys Acta 2008; 1777: 740-746.
197. Giorgio V, Bisetto E, Soriano ME, Dabbeni-Sala F, Basso E, Petronilli V et al. Cyclophilin D modulates mitochondrial F0F1-ATP synthase by interacting with the lateral stalk of the complex. J Biol Chem 2009; 284: 33982-33988.
198. Chinopoulos C, Konrad C, Kiss G, Metelkin E, Torocsik B, Zhang SF et al. Modulation of F0F1-ATP synthase activity by cyclophilin D regulates matrix adenine nucleotide levels. FEBS J 2011; 278: 1112-1125.
199. Alavian KN, Li H, Collis L, Bonanni L, Zeng L, Sacchetti S et al. Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase. Nat Cell Biol 2011; 13: 1224-1233.
200. Chen YB, Aon MA, Hsu YT, Soane L, Teng X, McCaffery JM et al. Bcl-xL regulates mitochondrial energetics by stabilizing the inner membrane potential. J Cell Biol 2011; 195: 263-276.
201. Perciavalle RM, Stewart DP, Koss B, Lynch J, Milasta S, Bathina M et al. Antiapoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration. Nat Cell Biol 2012; 14: 575-583.
202. Symersky J, Osowski D, Walters DE, Mueller DM. Oligomycin frames a common drug-binding site in the ATP synthase. Proc Natl Acad Sci USA 2012; 109: 13961-13965.
203. Shchepina LA, Pletjushkina OY, Avetisyan AV, Bakeeva LE, Fetisova EK, Izyumov DS et al. Oligomycin, inhibitor of the F0 part of H+-ATP-synthase, suppresses the TNF-induced apoptosis. Oncogene 2002; 21: 8149-8157.
204. Pucci B, Bertani F, Karpinich NO, Indelicato M, Russo MA, Farber JL et al. Detailing the role of Bax translocation, cytochrome c release, and perinuclear clustering of the mitochondria in the killing of HeLa cells by TNF. J Cell Physiol 2008; 217: 442-449.
205. Veenman L, Alten J, Linnemannstons K, Shandalov Y, Zeno S, Lakomek M et al. Potential involvement of F0F1-ATP(synth)ase and reactive oxygen species in apoptosis induction by the antineoplastic agent erucylphosphohomocholine in glioblastoma cell lines: a mechanism for induction of apoptosis via the 18 kDa mitochondrial translocator protein. Apoptosis 2010; 15: 753-768.
206. Giorgio V, von Stockum S, Antoniel M, Fabbro A, Fogolari F, Forte M et al. Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc Natl Acad Sci USA 2013; 110: 5887-5892.
207. Szabadkai G, Chinopoulos C. What makes you can also break you, part II: mitochondrial permeability transition pore formation by dimers of the F1FO ATP-synthase? Front Oncol 2013; 3: 140.
208. Masgras I, Rasola A, Bernardi P. Induction of the permeability transition pore in cells depleted of mitochondrial DNA. Biochim Biophys Acta 2012; 1817: 1860-1866.
209. Greie JC, Heitkamp T, Altendorf K. The transmembrane domain of subunit b of the Escherichia coli F1F(O) ATP synthase is sufficient for H(+)-translocating activity together with subunits a and c. Eur J Biochem 2004; 271: 3036-3042.
210. McGeoch JE, Guidotti G. A 0.1-700 Hz current through a voltage-clamped pore: candidate protein for initiator of neural oscillations. Brain Res 1997; 766: 188-194.
211. McGeoch JE, Palmer DN. Ion pores made of mitochondrial ATP synthase subunit c in the neuronal plasma membrane and Batten disease. Mol Genet Metab 1999; 66: 387-392.
212. Azarashvili TS, Tyynela J, Odinokova IV, Grigorjev PA, Baumann M, Evtodienko YV et al. Phosphorylation of a peptide related to subunit c of the F0F1-ATPase/ATP synthase and relationship to permeability transition pore opening in mitochondria. J Bioenerg Biomembr 2002; 34: 279-284.
213. Krestinina OV, Grachev DE, Odinokova IV, Reiser G, Evtodienko YV, Azarashvili TS. Effect of peripheral benzodiazepine receptor (PBR/TSPO) ligands on opening of Ca2+-induced pore and phosphorylation of 3.5-kDa polypeptide in rat brain mitochondria. Biochemistry (Mosc) 2009; 74: 421-429.
214. Bonora M, Bononi A, De Marchi E, Giorgi C, Lebiedzinska M, Marchi S et al. Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition. Cell Cycle 2013; 12: 674-683.
215. Azarashvili T, Odinokova I, Bakunts A, Ternovsky V, Krestinina O, Tyynela J et al. Potential role of subunit c of F0F1-ATPase and subunit c of storage body in the mitochondrial permeability transition. Effect of the phosphorylation status of subunit c on pore opening. Cell Calcium 2014; 55: 69-77.
216. Halestrap AP. What is the mitochondrial permeability transition pore? J Mol Cell Cardiol 2009; 46: 821-831.
217. Galluzzi L, Joza N, Tasdemir E, Maiuri MC, Hengartner M, Abrams JM et al. No death without life: vital functions of apoptotic effectors. Cell Death Differ 2008; 15: 1113-1123.
218. Galluzzi L, Kepp O, Trojel-Hansen C, Kroemer G. Non-apoptotic functions of apoptosis-regulatory proteins. EMBO Rep 2012; 13: 322-330.
219. Hao Z, Duncan GS, Chang CC, Elia A, Fang M, Wakeham A et al. Specific ablation of the apoptotic functions of cytochrome C reveals a differential requirement for cytochrome C and Apaf-1 in apoptosis. Cell 2005; 121: 579-591.